The global electroretinography (ERG) market was valued at USD 42.5 million in 2023 and is projected to reach USD 72.8 million by 2032, growing at a CAGR of 6.1% during 2024–2032. Growth is driven by the rising prevalence of retinal disorders, increasing demand for early ophthalmic disease diagnosis, and technological advancements in portable and multifocal ERG devices.

📌 Download a free sample report here:
https://www.datamintelligence.com/download-sample/electroretinography-market

Key Market Drivers

Rising Burden of Retinal Diseases
Growing cases of retinitis pigmentosa, age-related macular degeneration (AMD), diabetic retinopathy, and glaucoma increase demand for ERG testing.

Advancements in Ophthalmic Diagnostics
Emergence of multifocal ERG, handheld ERG systems, and AI-driven analysis improve diagnostic accuracy.

Aging Population
Higher incidence of ophthalmic diseases in the elderly supports sustained growth.

Clinical & Research Applications
Increased use of ERG in preclinical studies, drug development, and clinical ophthalmology.

Growing Awareness & Screening Programs
Government and NGO-led initiatives for early detection of diabetic eye diseases are boosting adoption.

Market Segmentation

By Product

• ERG Devices
• Electrodes & Consumables
• Software & Accessories
  📌 ERG devices dominate, but electrodes & consumables drive recurring revenue.

By Technology

• Full-Field ERG (ffERG)
• Pattern ERG (pERG)
• Multifocal ERG (mfERG)
  📌 Full-field ERG remains widely used, while mfERG is the fastest-growing for localized retinal dysfunction diagnosis.

By Application

• Clinical Diagnosis (Ophthalmology Clinics & Hospitals)
• Research & Drug Development
• Veterinary Ophthalmology
  📌 Clinical diagnosis holds the largest share, but research use is expanding steadily.

By End-User

• Hospitals & Eye Clinics
• Research Institutes & Universities
• Veterinary Clinics

Regional Insights

North America – Largest market with high adoption of advanced ophthalmic diagnostic tools, strong presence of ERG device manufacturers, and high healthcare spending.
Europe – Significant share due to supportive reimbursement policies and growing prevalence of retinal disorders in aging populations.
Asia-Pacific – Fastest-growing region, driven by increasing diabetic retinopathy cases in China, India, and Japan, rising awareness, and growing healthcare infrastructure.
Latin America & Middle East – Emerging adoption, particularly in Brazil, Mexico, and GCC countries with expanding ophthalmology practices.

Recent Industry Trends

• Portable & handheld ERG systems improving accessibility for clinics and field screening.
• Integration of AI & cloud-based platforms for faster interpretation and teleophthalmology.
• Multifocal ERG gaining adoption for early detection of localized retinal dysfunction.
• Veterinary ERG applications expanding for diagnosing inherited retinal diseases in animals.
• Growing collaborations with pharma companies for drug efficacy testing in ophthalmology trials.

Competitive Landscape

Key players include:

• Diagnosys LLC
• LKC Technologies, Inc.
• Roland Consult Stasche & Finger GmbH
• Metrovision
• Haag-Streit Group
• Nidek Co., Ltd.
• Konan Medical USA, Inc.

📌 Market players focus on product innovation, AI-driven ERG systems, and geographic expansion.

Growth Opportunities

• Increasing AI-driven ERG analytics for automated diagnosis
• Expanding use of ERG in clinical trials for novel ophthalmic drugs
• Rising demand in veterinary ophthalmology for companion animals
• Portable ERG devices enabling point-of-care and rural diagnostics
• Government-led vision screening programs in emerging economies

Challenges

• High cost of ERG systems limiting adoption in low-income regions
• Limited awareness among primary care providers about ERG testing
• Lack of trained specialists for advanced ERG interpretation
• Reimbursement issues in developing countries

📌 Buy the full report here:
https://www.datamintelligence.com/buy-now-page?report=electroretinography-market

Conclusion

The electroretinography market is set for robust growth, driven by the rising prevalence of retinal disorders, increasing adoption of portable ERG devices, and expanding research applications. While North America leads in adoption, Asia-Pacific is expected to emerge as the fastest-growing market due to its high diabetic population and expanding healthcare infrastructure.